ATE170532T1 - PROSTAGLANDIN RECEPTOR FP AND CODING DNA - Google Patents
PROSTAGLANDIN RECEPTOR FP AND CODING DNAInfo
- Publication number
- ATE170532T1 ATE170532T1 AT94918699T AT94918699T ATE170532T1 AT E170532 T1 ATE170532 T1 AT E170532T1 AT 94918699 T AT94918699 T AT 94918699T AT 94918699 T AT94918699 T AT 94918699T AT E170532 T1 ATE170532 T1 AT E170532T1
- Authority
- AT
- Austria
- Prior art keywords
- prostaglandin receptor
- receptor
- coding dna
- host cells
- dna encoding
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/686—Anti-idiotype
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A novel prostaglandin receptor has been identified and DNA encoding the receptor has been isolated, purified, sequenced and expressed in host cells. This DNA encoding the novel prostaglandin receptor and host cells expressing the receptor are used to identify modulators of the prostaglandin receptor.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/083,741 US5869281A (en) | 1993-06-25 | 1993-06-25 | DNA encoding prostaglandin receptor FP |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE170532T1 true ATE170532T1 (en) | 1998-09-15 |
Family
ID=22180389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94918699T ATE170532T1 (en) | 1993-06-25 | 1994-06-09 | PROSTAGLANDIN RECEPTOR FP AND CODING DNA |
Country Status (9)
Country | Link |
---|---|
US (3) | US5869281A (en) |
EP (1) | EP0705276B1 (en) |
JP (1) | JP3228751B2 (en) |
AT (1) | ATE170532T1 (en) |
AU (1) | AU6991894A (en) |
CA (1) | CA2165954C (en) |
DE (1) | DE69413039T2 (en) |
ES (1) | ES2120052T3 (en) |
WO (1) | WO1995000551A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9202892D0 (en) | 1992-10-02 | 1992-10-02 | Kabi Pharmacia Ab | DNA ENCODING A PROSTAGLANDIN RECEPTOR, A HOST CELL TRANSFORMED THEREWITH AND AN EXPRESSION PRODUCT THEREOF |
US6057433A (en) * | 1993-11-19 | 2000-05-02 | Allergan Sales, Inc. | Nucleic acid encoding human EP3 prostaglandin receptor |
US6670134B1 (en) | 1993-11-19 | 2003-12-30 | Allergan, Inc. | Human EP3 prostaglandin receptor |
US7294331B2 (en) | 1994-03-07 | 2007-11-13 | Immunex Corporation | Methods of using flt3-ligand in hematopoietic cell transplantation |
WO1996023066A2 (en) * | 1995-01-26 | 1996-08-01 | Merck Frosst Canada Inc. | Prostaglandin receptor, dp |
US5955575A (en) * | 1997-12-22 | 1999-09-21 | Hopital Sainte-Justine | Antagonists of G-protein-coupled receptor |
CA2342960C (en) | 1998-09-17 | 2010-03-09 | Hopital Sainte-Justine | G protein-coupled receptor antagonists |
US6984719B1 (en) | 1998-09-17 | 2006-01-10 | Hospital Sainte-Justine | Peptide antagonists of prostaglandin F2α receptor |
AU9756898A (en) * | 1998-11-12 | 2000-06-05 | Gemini Genomics Ab | Human prostaglandin receptors and methods of use thereof |
WO2000051980A1 (en) | 1999-03-05 | 2000-09-08 | The Procter & Gamble Company | C16 unsaturated fp-selective prostaglandins analogs |
US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
AU784630B2 (en) | 1999-12-06 | 2006-05-18 | Hopital Sainte-Justine | Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
DE60236951D1 (en) * | 2001-05-21 | 2010-08-19 | Fujifilm Corp | Apparatus for carrying out biochemical analyzes and process for their preparation |
US7521530B2 (en) | 2002-06-11 | 2009-04-21 | Universite De Montreal | Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor |
WO2004073590A2 (en) * | 2003-02-24 | 2004-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for deseases associated with g-protein coupled receptor prostaglandin f2-alpha (prostaglandin f2-alpha) |
US7320871B2 (en) * | 2003-07-14 | 2008-01-22 | Allergan, Inc. | Human prostaglandin FP receptor variants and methods of using same |
US20050074847A1 (en) * | 2003-10-07 | 2005-04-07 | Yanbin Liang | Human prostaglandin EP1 receptor variants and methods of using same |
US20050084929A1 (en) * | 2003-10-17 | 2005-04-21 | Yanbin Liang | Human prostaglandin EP4 receptor variants and methods of using same |
US20050084931A1 (en) * | 2003-10-20 | 2005-04-21 | Yanbin Liang | Human prostaglandin DP receptor variants and methods of using same |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9202892D0 (en) * | 1992-10-02 | 1992-10-02 | Kabi Pharmacia Ab | DNA ENCODING A PROSTAGLANDIN RECEPTOR, A HOST CELL TRANSFORMED THEREWITH AND AN EXPRESSION PRODUCT THEREOF |
-
1993
- 1993-06-25 US US08/083,741 patent/US5869281A/en not_active Expired - Lifetime
-
1994
- 1994-06-09 CA CA002165954A patent/CA2165954C/en not_active Expired - Fee Related
- 1994-06-09 ES ES94918699T patent/ES2120052T3/en not_active Expired - Lifetime
- 1994-06-09 DE DE69413039T patent/DE69413039T2/en not_active Expired - Lifetime
- 1994-06-09 AT AT94918699T patent/ATE170532T1/en not_active IP Right Cessation
- 1994-06-09 EP EP94918699A patent/EP0705276B1/en not_active Expired - Lifetime
- 1994-06-09 AU AU69918/94A patent/AU6991894A/en not_active Abandoned
- 1994-06-09 JP JP50226995A patent/JP3228751B2/en not_active Expired - Fee Related
- 1994-06-09 WO PCT/CA1994/000319 patent/WO1995000551A1/en active IP Right Grant
-
1997
- 1997-11-21 US US08/976,074 patent/US5840847A/en not_active Expired - Lifetime
- 1997-11-21 US US08/976,166 patent/US6358694B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2165954A1 (en) | 1995-01-05 |
EP0705276B1 (en) | 1998-09-02 |
WO1995000551A1 (en) | 1995-01-05 |
EP0705276A1 (en) | 1996-04-10 |
US5840847A (en) | 1998-11-24 |
ES2120052T3 (en) | 1998-10-16 |
JPH11505701A (en) | 1999-05-25 |
AU6991894A (en) | 1995-01-17 |
CA2165954C (en) | 2005-04-26 |
DE69413039D1 (en) | 1998-10-08 |
DE69413039T2 (en) | 1999-05-06 |
US5869281A (en) | 1999-02-09 |
JP3228751B2 (en) | 2001-11-12 |
US6358694B1 (en) | 2002-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE170532T1 (en) | PROSTAGLANDIN RECEPTOR FP AND CODING DNA | |
DE69432470D1 (en) | DNA CODING FOR PROSTAGLANDIN RECEPTOR IP | |
CA2170509A1 (en) | Dna encoding prostaglandin receptor ep2 | |
DE69518751D1 (en) | PURIFIED SCYTALIDIUM LACASSES AND NUCLEIC ACIDS CODING THEM | |
DE69836088D1 (en) | AS LERK6 DESIGNATED CYTOKIN | |
WO1996023066A3 (en) | Prostaglandin receptor, dp | |
ATE157398T1 (en) | PROSTAGLANDIN RECEPTOR EP1 CODING DNA | |
ATE196651T1 (en) | DNA CODING FOR THE ALPHA-1E SUBUNIT OF THE HUMAN CALCIUM CHANNEL | |
ATE73846T1 (en) | MICROORGANISMS. | |
ATE415480T1 (en) | B7L-1 MOLECULES | |
ATE172471T1 (en) | PROSTAGLANDIN RECEPTOR EP3 AND CODING DNA | |
DE69535316D1 (en) | AS LERK6 DESIGNATED CYTOKIN | |
DE69939587D1 (en) | Semaphorin polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |